STOCK CAPITAL (Tables)
|
6 Months Ended |
Jun. 30, 2018 |
| Disclosure of Compensation Related Costs, Share-based Payments [Abstract] |
|
| Schedule of Composition of Common Stock Capital |
| |
|
Authorized
|
|
|
Issued and outstanding
|
|
| |
|
Number of shares
|
|
| |
|
June 30,
2018
|
|
|
December 31,
2017
|
|
|
June 30,
2018
|
|
|
December 31,
2017
|
|
| |
|
(unaudited)
|
|
|
|
|
|
(unaudited)
|
|
|
|
|
|
Stock of $0.0001 par value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock
|
|
|
125,000,000
|
|
|
|
125,000,000
|
|
|
|
45,498,414
|
|
|
|
43,812,601
|
|
|
| Schedule of Stock Option Activity |
A summary of the activity in the share options granted to employees and members of the board of directors for the six months ended June 30, 2018 (unaudited) and related information follows:
| |
|
|
|
|
|
|
|
Weighted
|
|
|
|
|
| |
|
|
|
|
|
|
|
average
|
|
|
|
|
| |
|
|
|
|
Weighted
|
|
|
remaining
|
|
|
|
|
| |
|
Number
|
|
|
average
|
|
|
contractual
|
|
|
Aggregate
|
|
| |
|
of
|
|
|
exercise
|
|
|
term
|
|
|
intrinsic
|
|
| |
|
Options
|
|
|
price
|
|
|
in years
|
|
|
Value
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding as of December 31, 2017
|
|
|
3,524,310
|
|
|
|
7.40
|
|
|
|
6.35
|
|
|
|
106,251
|
|
|
Granted
|
|
|
180,983
|
|
|
|
38.05
|
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(1,219,007
|
)
|
|
|
4.86
|
|
|
|
|
|
|
|
|
|
|
Forfeited or expired
|
|
|
(22,677
|
)
|
|
|
8.46
|
|
|
|
|
|
|
|
|
|
|
Outstanding as of June 30, 2018
|
|
|
2,463,609
|
|
|
|
10.90
|
|
|
|
6.68
|
|
|
|
91,022
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vested and expected to vest as of June 30, 2018
|
|
|
2,395,526
|
|
|
|
10.81
|
|
|
|
6.66
|
|
|
|
88,724
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable as of June 30, 2018
|
|
|
1,564,382
|
|
|
|
7.12
|
|
|
|
5.93
|
|
|
|
63,722
|
|
|
| Schedule of RSU Activity |
|
d. |
A summary of the activity in the RSUs granted to employees and members of the board of directors for the six months ended June 30, 2018 (unaudited) is as follows:
|
| |
|
No. of
RSUs
|
|
|
Weighted average
grant date
fair value
|
|
|
Unvested as of December 31, 2017
|
|
|
2,087,992
|
|
|
|
24.33
|
|
|
Granted
|
|
|
531,729
|
|
|
|
48.15
|
|
|
Vested
|
|
|
(393,939
|
)
|
|
|
21.16
|
|
|
Forfeited
|
|
|
(125,989
|
)
|
|
|
6.62
|
|
|
Unvested as of June 30, 2018
|
|
|
2,099,793
|
|
|
|
30.71
|
|
|
| Schedule of Options and RSUs Granted to Non-Employee Consultants |
The Company has granted options and RSUs to purchase common shares to non-employee consultants as of June 30, 2018 (unaudited) as follows:
| |
|
Outstanding
|
|
|
|
|
|
Exercisable
|
|
|
| |
|
as of
|
|
|
|
|
|
as of
|
|
|
|
|
|
June 30,
|
|
|
Exercise
|
|
|
June 30,
|
|
Exercisable
|
|
Issuance Date
|
|
2018
|
|
|
price
|
|
|
2018
|
|
Through
|
| |
|
|
|
|
|
|
|
|
|
|
|
January 27, 2014
|
|
|
225
|
|
|
|
3.51
|
|
|
|
31
|
|
January 27, 2024
|
|
May 1, 2014
|
|
|
1,205
|
|
|
|
3.51
|
|
|
|
1,205
|
|
May 1, 2024
|
|
September 17, 2014
|
|
|
3,936
|
|
|
|
3.96
|
|
|
|
3,831
|
|
September 17, 2024
|
|
October 29, 2014
|
|
|
2,139
|
|
|
|
5.01
|
|
|
|
361
|
|
October 29, 2024
|
|
August 19, 2015
|
|
|
6,981
|
|
|
|
0.00
|
|
|
|
-
|
|
-
|
|
November 8, 2015
|
|
|
928
|
|
|
|
0.00
|
|
|
|
-
|
|
- |
|
April 18, 2016
|
|
|
834
|
|
|
|
0.00
|
|
|
|
-
|
|
- |
|
July 11, 2016
|
|
|
1,167
|
|
|
|
0.00
|
|
|
|
-
|
|
- |
|
September 21, 2016
|
|
|
2,500
|
|
|
|
15.34
|
|
|
|
250
|
|
September 21, 2026
|
|
September 21, 2016
|
|
|
3,938
|
|
|
|
0.00
|
|
|
|
-
|
|
- |
|
March 15, 2017
|
|
|
6,000
|
|
|
|
0.00
|
|
|
|
-
|
|
- |
|
March 15, 2017
|
|
|
6,500
|
|
|
|
13.70
|
|
|
|
500
|
|
March 15, 2027
|
|
March 27, 2017
|
|
|
3,000
|
|
|
|
0.00
|
|
|
|
-
|
|
-
|
|
November 20, 2017
|
|
|
5,250
|
|
|
|
0.00
|
|
|
|
-
|
|
- |
|
January 2, 2018
|
|
|
6,160
|
|
|
|
0.00
|
|
|
|
-
|
|
- |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
50,763
|
|
|
|
|
|
|
|
6,178
|
|
|
|
| Schedule of Recognized Stock-Based Compensation Expense |
The Company recognized stock-based compensation expenses related to stock options and RSUs granted to employees and non-employees and ESPP in the condensed consolidated statement of operations for the six months ended on June 30, 2018 (unaudited) and 2017 (unaudited), as follows:
| |
|
Three months ended
June 30,
|
|
|
Six months ended
June 30,
|
|
| |
|
2018
|
|
|
2017
|
|
|
2018
|
|
|
2017
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenues
|
|
$
|
968
|
|
|
$
|
517
|
|
|
$
|
1,892
|
|
|
$
|
1,010
|
|
|
Research and development
|
|
|
2,605
|
|
|
|
1,280
|
|
|
|
4,987
|
|
|
|
2,485
|
|
|
Selling and marketing
|
|
|
2,094
|
|
|
|
1,204
|
|
|
|
4,298
|
|
|
|
2,234
|
|
|
General and administrative
|
|
|
1,461
|
|
|
|
1,033
|
|
|
|
2,800
|
|
|
|
1,917
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total stock-based compensation expense
|
|
$
|
7,128
|
|
|
$
|
4,034
|
|
|
$
|
13,977
|
|
|
$
|
7,646
|
|
|